Fredun Pharmaceuticals Ltd (NSE: FREDUN), ISIN INE194R01017 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
FREDUN last traded at ₹920.00 (+1.41%), with a 52-week range of ₹319.68 to ₹999.00 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 43.06%, FIIs 0.46%, DIIs 3.48%, mutual funds 0.00%.
EquiSense Score (ECS): 86/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.